Absorption and distribution of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA2370) in the rat.
D000475:Alkenes / Q000008:administration & dosage / Q000378:metabolism*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000378:metabolism*; D004487:Edema / Q000378:metabolism; D005243:Feces / Q000032:analysis; D007408:Intestinal Absorption; D008297:Male; D010653:Phenylbutazone / Q000008:administration & dosage / Q000378:metabolism; D011720:Pyrazoles / Q000008:administration & dosage / Q000378:metabolism*; D051381:Rats
D000475:Alkenes; D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D010653:Phenylbutazone